OCTREOTIDE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 37 adverse event reports in the FDA FAERS database where OCTREOTIDE was used for Psoriasis.
Most Reported Side Effects for OCTREOTIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 3,801 | 16.0% | 3,790 | 994 |
| Diarrhoea | 3,621 | 15.3% | 551 | 1,907 |
| Fatigue | 2,933 | 12.4% | 512 | 1,681 |
| Blood pressure increased | 2,799 | 11.8% | 478 | 1,641 |
| Needle issue | 2,740 | 11.6% | 217 | 864 |
| Malaise | 2,737 | 11.5% | 520 | 1,680 |
| Pain | 2,366 | 10.0% | 427 | 1,469 |
| Blood pressure systolic increased | 2,340 | 9.9% | 519 | 1,438 |
| Malignant neoplasm progression | 2,306 | 9.7% | 610 | 1,109 |
| Nausea | 2,294 | 9.7% | 377 | 1,306 |
| Injection site pain | 2,123 | 9.0% | 315 | 1,164 |
| Abdominal pain | 2,033 | 8.6% | 380 | 1,310 |
| Asthenia | 1,975 | 8.3% | 543 | 1,330 |
| Weight decreased | 1,950 | 8.2% | 440 | 1,236 |
| Inappropriate schedule of product administration | 1,921 | 8.1% | 334 | 989 |
Other Indications for OCTREOTIDE
Product used for unknown indication (6,866)
Neuroendocrine tumour (4,587)
Acromegaly (3,068)
Carcinoid tumour (2,148)
Carcinoid syndrome (1,367)
Pancreatic neuroendocrine tumour (647)
Gastroenteropancreatic neuroendocrine tumour disease (387)
Diarrhoea (338)
Neuroendocrine carcinoma (251)
Metastatic carcinoid tumour (192)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)